Literature DB >> 17940551

Fragile X: translation in action.

Mark F Bear1, Gül Dölen, Emily Osterweil, Naveen Nagarajan.   

Abstract

Fragile X is a synapsopathy--a disorder of synaptic function and plasticity. Recent studies using mouse models of the disease suggest that the critical defect is altered regulation of synaptic protein synthesis. Various strategies to restore balanced synaptic protein synthesis have been remarkably successful in correcting widely varied mutant phenotypes in mice. Insights gained by the study of synaptic plasticity in animal models of fragile X have suggested novel therapeutic approaches, not only for human fragile X but also for autism and mental retardation of unknown etiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940551      PMCID: PMC4327813          DOI: 10.1038/sj.npp.1301610

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  26 in total

1.  Synaptic assembly of the brain in the absence of neurotransmitter secretion.

Authors:  M Verhage; A S Maia; J J Plomp; A B Brussaard; J H Heeroma; H Vermeer; R F Toonen; R E Hammer; T K van den Berg; M Missler; H J Geuze; T C Südhof
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression.

Authors:  K M Huber; M S Kayser; M F Bear
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

Review 3.  Bidirectional synaptic plasticity: from theory to reality.

Authors:  Mark F Bear
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

4.  A morphological correlate of synaptic scaling in visual cortex.

Authors:  Wes Wallace; Mark F Bear
Journal:  J Neurosci       Date:  2004-08-04       Impact factor: 6.167

5.  How monocular deprivation shifts ocular dominance in visual cortex of young mice.

Authors:  Mikhail Y Frenkel; Mark F Bear
Journal:  Neuron       Date:  2004-12-16       Impact factor: 17.173

Review 6.  Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond.

Authors:  Aaron W Grossman; Georgina M Aldridge; Ivan Jeanne Weiler; William T Greenough
Journal:  J Neurosci       Date:  2006-07-05       Impact factor: 6.167

7.  Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons.

Authors:  Peter W Vanderklish; Gerald M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 8.  Synaptic activity and the construction of cortical circuits.

Authors:  L C Katz; C J Shatz
Journal:  Science       Date:  1996-11-15       Impact factor: 47.728

Review 9.  Differential translation and fragile X syndrome.

Authors:  P W Vanderklish; G M Edelman
Journal:  Genes Brain Behav       Date:  2005-08       Impact factor: 3.449

10.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

Authors:  Q J Yan; M Rammal; M Tranfaglia; R P Bauchwitz
Journal:  Neuropharmacology       Date:  2005-07-27       Impact factor: 5.250

View more
  54 in total

1.  Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome.

Authors:  Michael Feyder; Rose-Marie Karlsson; Poonam Mathur; Matthew Lyman; Roland Bock; Reza Momenan; Jeeva Munasinghe; Maria Luisa Scattoni; Jessica Ihne; Marguerite Camp; Carolyn Graybeal; Douglas Strathdee; Alison Begg; Veronica A Alvarez; Peter Kirsch; Marcella Rietschel; Sven Cichon; Henrik Walter; Andreas Meyer-Lindenberg; Seth G N Grant; Andrew Holmes
Journal:  Am J Psychiatry       Date:  2010-10-15       Impact factor: 18.112

Review 2.  Fragile X: leading the way for targeted treatments in autism.

Authors:  Lulu W Wang; Elizabeth Berry-Kravis; Randi J Hagerman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 3.  Reversing neurodevelopmental disorders in adults.

Authors:  Dan Ehninger; Weidong Li; Kevin Fox; Michael P Stryker; Alcino J Silva
Journal:  Neuron       Date:  2008-12-26       Impact factor: 17.173

4.  Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.

Authors:  Wenzhong William Min; Christopher J Yuskaitis; Qijiang Yan; Christopher Sikorski; Shengqiang Chen; Richard S Jope; Robert P Bauchwitz
Journal:  Neuropharmacology       Date:  2008-10-14       Impact factor: 5.250

Review 5.  Synaptic competition in structural plasticity and cognitive function.

Authors:  Yazmín Ramiro-Cortés; Anna F Hobbiss; Inbal Israely
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

6.  Intracellular GPCRs Play Key Roles in Synaptic Plasticity.

Authors:  Yuh-Jiin I Jong; Steven K Harmon; Karen L O'Malley
Journal:  ACS Chem Neurosci       Date:  2018-02-16       Impact factor: 4.418

Review 7.  The genetics of autism: key issues, recent findings, and clinical implications.

Authors:  Paul El-Fishawy; Matthew W State
Journal:  Psychiatr Clin North Am       Date:  2010-03

8.  Microtubule-dependent association of AKAP350A and CCAR1 with RNA stress granules.

Authors:  Elena Kolobova; Andrey Efimov; Irina Kaverina; Arun K Rishi; John W Schrader; Amy-Joan Ham; M Cecilia Larocca; James R Goldenring
Journal:  Exp Cell Res       Date:  2008-12-03       Impact factor: 3.905

9.  Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.

Authors:  Dan Ehninger; Sangyeul Han; Carrie Shilyansky; Yu Zhou; Weidong Li; David J Kwiatkowski; Vijaya Ramesh; Alcino J Silva
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

10.  Open-label memantine in fragile X syndrome.

Authors:  Craig A Erickson; Jennifer E Mullett; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.